PLA2G4E Antikörper
-
- Target Alle PLA2G4E Antikörper anzeigen
- PLA2G4E (Phospholipase A2, Group IVE (PLA2G4E))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLA2G4E Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), Western Blotting (WB)
- Isotyp
- IgG
- Top Product
- Discover our top product PLA2G4E Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:1000. IHC: 1:50-1:100
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
- Lagerung
- 4 °C,-20 °C
-
- Target
- PLA2G4E (Phospholipase A2, Group IVE (PLA2G4E))
- Andere Bezeichnung
- PLA2G4E (PLA2G4E Produkte)
- Hintergrund
- Calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position (By similarity).
- Molekulargewicht
- 97570 Da
- Gen-ID
- 123745
- UniProt
- Q3MJ16
- Pathways
- Inositol Metabolic Process, VEGF Signaling
-